The disposition of theophylline in camels after intravenous administration

Journal of Veterinary Pharmacology and Therapeutics

Volumn 22, Issue 4, 1999, Pages 255-260

  Wasfi, Ibrahim A ^a   Elghazali, M ^a   Boni, N S ^a   Hadi, A A A ^a   Alhadrami, G A ^b   Almuhrami, A M ^a   Alkatheeri, N A ^a   Barezaiq, I M ^a   Agha, B A O ^a   Wajid, S A ^a  

^a Forensic Science Laboratory Abu Dhabi   (United Arab Emirates)

^b UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHODILATING AGENT; CAFFEINE; THEOPHYLLINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CAMEL; CONTROLLED STUDY; DRUG CLEARANCE; DRUG DISPOSITION; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG PROTEIN BINDING; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY CLEARANCE; MALE; NONHUMAN; PRIORITY JOURNAL; THEOPHYLLINE BLOOD LEVEL;

ANIMALS; AREA UNDER CURVE; BRONCHODILATOR AGENTS; CAMELS; FEMALE; INJECTIONS, INTRAVENOUS; MALE; THEOPHYLLINE;

ANIMALIA; CAMELIDAE;

EID: 0032870810     PISSN: 01407783     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2885.1999.00220.x     Document Type: Article

References (31)

1. Alberola, J., Perez, Y., Puigdemont, A. & Arboix, M. (1993) Effect of age on theophylline pharmacokinetics in dogs. American Journal of Veterinary Research, 54, 1112-1115.
2. Alkatheeri, N.A., Wasfi, I.A. & Lambert, M. (1999) Pharmacokinetics and metabolism of ketoprofen after intravenous and intramuscular administration in camels. Journal of Veterinary Pharmacology and Therapeutics, 22, 127-135.
3. Armbruster, D.A., Tillman, M.D. & Hubs, L.M. (1994) Limit of detection (LOD) / limit of quantitation (LOQ): Comparison of the empirical and the statistical methods exemplified with GC-MS assays or abused drugs. Clinical Chemistry, 40, 1233-1238.
4. Brors, O., Sager, G., Sandnes, D. & Jacobosen, S. (1983) Binding of theophylline in human serum determined by ultra-filtration and equilibrium dialysis. British Journal of Clinical Pharmacology, 15, 393-397.
5. El-Yazigi, A. & Sawchuck, R.J. (1981) Theophylline absorption and disposition in rabbits: oral, intravenous and concentration-dependent and kinetic studies. Journal of Pharmaceutical Science, 70, 452-456.
6. Errecalde, J.O., Button, C., Baggot, J.D. & Mulders, M.S.G. (1984) Pharmacokinetics and bioavailability of theophylline in horses. Journal of Veterinary Pharmacology and Therapeutics, 7, 255-263.
7. Errecalde, J.O., Button, C. & Mulders, M.S.G. (1985) Some dynamic and toxic effects of theophylline in horses. Journal of Veterinary Pharmacology and Therapeutics, 8, 320-327.
8. Errecalde, J.O. & Lundoni, M.F. (1992) The pharmacokinetics of slow-release theophylline preparation in horses after intravenous and oral administration. Veterinary Research Communications, 16, 131-138.
9. Gibaldi, M. & Perrier, D. (1982) Pharmacokinetics. Ed. Dekker, M. pp. 45-108. Plenum Press, New York.
10. Grygiel, J.J., Wing, L.M., Farkas, J. & Birkett, D.J. (1979) Effects of allopurinol on theophylline metabolism and clearance. Clinical Pharmacology and Therapeutics, 26, 660-667.
11. Harkins, J.D., Mundy, G.D., Stanely, S.D. & Tobin, T. (1998) An overview of the methylxanthines and their regulation in the horse. Equine Practice, 20, 10-16.
12. Ingvast-Larsson, C., Kallings, P., Persson, S., Appelgren, L.E. & Wiese, B. (1989) Pharmacokinetics and cardio-respiratory effects of oral theophylline in exercised horses. Journal of Veterinary Pharmacology and Therapeutics, 12, 189-199.
13. Ingvast-Larsson, C., Paalzow, G., Paalzow, L., Ottoson, T., Lindholm, A. & Appelgren, L.E. (1983) Pharmacokinetic studies of theophylline in horses. Journal of Veterinary Pharmacology and Therapeutics, 8, 76-81.
14. Koritz, G.D., Bourne, D.W.A., Hunt, J.P., Prasad, V.I., Bevill, R.F. & Gautam, S.R. (1981) Pharmacokinetics of theophylline in swine: a potential model for human drug bioavailability studies. Journal of Veterinary Pharmacology and Therapeutics, 4, 231-239.
15. Lambert, M.B.T. & Evans, J.A. (1983) Drug clearance in the racehorse: a review. Irish Veterinary Journal, 37, 9-13.
16. Langston, V.C., Koritz, G.D., Davis, L.E. & Neff-Davis, C. (1989) Pharmacokinetic properties of theophylline given intravenously and orally to ruminating calves. American Journal of Veterinary Research, 50, 493-497.
17. McKiernan, B.C., Koritz, G.D., Davis, L.E., Neff-Davis, C.A. & Pheris, D.R. (1983) Pharmacokinetic studies of theophylline in cats. Journal of Veterinary Pharmacology and Therapeutics, 6, 99-104.
18. McKiernan, B.C., Neff-Davis, C.A., Kortiz, G.D., Davis, L.E. & Pheris, D.R. (1981) Pharmacokinetic studies or theophylline in dogs. Journal of Veterinary Pharmacology and Therapeutics, 4, 103-110.
19. O'Shea, D., Kim, R.B. & Wilkinson, G.R. (1997) Modulation of CYP2EI activity by isoniazid and slow N-acetylators. British Journal of Clinical Pharmacology, 43, 99-103.
20. Ogilvie, R.I. (1978) Pharmacokinetics of theophylline. Clinical Pharmacokinetics, 3, 267-293.
21. Perez, Y., Puigdemont, A. Cristofol, C., De Mora, F. & Arboix, M. (1994) Comparison of theophylline pharmacokinetics in yearling and 4-year old horses. Journal of Veterinary Pharmacology and Therapeutics, 17, 473-476.
22. Rall, T.W. (1993) Drugs used in the treatment of asthma. In The Pharmacological Basis of Therapeutics, Ed. Gilman, A., pp. 618-637. Macmillan Publishing Co, Inc., New York.
23. Rasmussen, B.B. & Brosen, K. (1997) Theophylline has no advantage over caffeine as a putative model drug for assaying CYP 1A2 activity in humans. British Journal of Clinical Pharmacology, 43, 253-258.
24. Rasmussen, B.B., Jeppesen, U., Gaist, D. & Brosen, K. (1997) Griseofulvin and fluvoxamine interact with the metabolism of theophylline. Therapeutic Drug Monitoring, 19, 56-62.
25. Rasmussen, B.R., Maenpaa, J., Pelkonen, O., Loft, S., Poulsen, H.E., Lykkesfeldt, J. & Brosen, K. (1995) Selective serotonin reuptake inhibitors and theophylline metabolism in human liver microsomes: potent inhibition by fluvoxamine. British Journal of Clinical Pharmacology, 39, 151-159.
26. Robson, R.A., Miners, J.O. & Matthews, A.P. (1988) Characterization of theophylline metabolism by human liver microsomes. Inhibition and immunochemical studies. Biochemical Pharmacology, 37, 1651-1659.
27. Thomson, J.R. & McPherson, E.A. (1983) Chronic obstructive pulmonary disease in the horse. Equine Veterinary Journal, 15, 207-210.
28. Wasfi, I.A., Abdel Hadi, A.A., Zorob, O., Osman, M.E. & Boni, N.S. (1997) Pharmacokinetics of phenylbutazone in camels. American Journal of Veterinary Research, 58, 636-640.
29. Wasfi, I.A., Boni, N.S., Abdel Hadi, A.A., El Ghazali, M., Zorob, O., Alkatheeri, N.A. & Barezaiq, I.M. (1998a) Pharmacokinetics, metabolism and urinary detection time of flunixin after intravenous administration in camels. Journal of Veterinary Pharmacology and Therapeutics, 21, 203-208.
30. Wasfi, I.A., El Ghazali, M., Hadi, A.A.A., Zorob, O., Boni, N.S., Alkatheeri, N.A. & Barezaiq, I.M. (1998b) Pharmacokinetics of tolfenamic acid and its detection time in urine after intravenous administration of the drug in camels (Camelus dromedarius). American Journal of Veterinary Research, 11, 1451-1458.
31. Wilson, R.T. (1984) The camel. The Print House Tte., Singapore.